ConductScience.org, home
Papers
API referenceFor AI assistants

Paper41535643

The mRNA-Based Innovative Strategy: Progress and Challenges.

Zhou H and 10 others. Nanomicro Lett, 2026. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The mRNA-Based Innovative Strategy: Progress and Challenges. Papers, record 41535643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41535643

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The mRNA-Based Innovative Strategy: Progress and Challenges.
PubMed
Journal
Nanomicro Lett
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
5.41, provisional
iCite
Revised in PubMed
2026-09-20
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhou HHuayuan
2Wei DDali
3Chen ZZhejie
4Chen HHao
5Dong CChuhuang
6Yao WWei
7Wang JJiawen
8Liu XXueliang
9Li YYuqing
10Yang YYu
11Tan WWeihong

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References295

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133,524,237Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap® Analog by In Vitro Transcription.Curr Protoc2021https://conductscience.org/library/papers/33524237PubMed
232,728,218An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.Nature2020https://conductscience.org/library/papers/32728218PubMed
336,563,159Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants.Sci Adv2022https://conductscience.org/library/papers/36563159PubMed
422,687,619In vitro capping and transcription of rhabdoviruses.Methods2013https://conductscience.org/library/papers/22687619PubMed
533,594,887In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy.Nano Lett2021https://conductscience.org/library/papers/33594887PubMed
636,679,975An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis.Vaccines (Basel)2023https://conductscience.org/library/papers/36679975PubMed
716,111,635Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.Immunity2005https://conductscience.org/library/papers/16111635PubMed
838,452,271Fluorinated Lipid Nanoparticles for Enhancing mRNA Delivery Efficiency.ACS Nano2024https://conductscience.org/library/papers/38452271PubMed
913,956,740Foreign nucleic acids as the stimulus to make interferon.Lancet1963https://conductscience.org/library/papers/13956740PubMed
101,002,690mRNA guanylyltransferase and mRNA (guanine-7-)-methyltransferase from vaccinia virions. Donor and acceptor substrate specificites.J Biol Chem1976https://conductscience.org/library/papers/1002690PubMed
1139,354,147Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery.Nat Nanotechnol2025https://conductscience.org/library/papers/39354147PubMed
1229,980,618Revisiting IL-2: Biology and therapeutic prospects.Sci Immunol2018https://conductscience.org/library/papers/29980618PubMed
1323,360,964Efficient genome editing in zebrafish using a CRISPR-Cas system.Nat Biotechnol2013https://conductscience.org/library/papers/23360964PubMed
1434,907,393Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.Nat Med2022https://conductscience.org/library/papers/34907393PubMed
1536,430,387Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches.Int J Mol Sci2022https://conductscience.org/library/papers/36430387PubMed
1638,255,961Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis.Int J Mol Sci2024https://conductscience.org/library/papers/38255961PubMed
1718,991,638Polyethylenimine in medicinal chemistry.Curr Med Chem2008https://conductscience.org/library/papers/18991638PubMed
1838,490,213Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers.Cancer Cell2024https://conductscience.org/library/papers/38490213PubMed
1937,206,219Nanomaterials for mRNA-based therapeutics: Challenges and opportunities.Bioeng Transl Med2023https://conductscience.org/library/papers/37206219PubMed
2018,797,453Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.Mol Ther2008https://conductscience.org/library/papers/18797453PubMed

See all 295 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42,877,411Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application.Front Genome Ed2026https://conductscience.org/library/papers/42877411PubMed
42,840,189Intranasal Netrin-1 modRNA-Loaded Extracellular Vesicles Reduce Neuronal Apoptosis after Ischemic Stroke.Biomater Res2026https://conductscience.org/library/papers/42840189PubMed
42,780,376Emerging strategies and innovations in circular RNA synthesis.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42780376PubMed
42,765,443mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives.Immun Inflamm Dis2026https://conductscience.org/library/papers/42765443PubMed
42,651,807Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42651807PubMed
42,621,705Dual-Gene Edited Extracellular Vesicles Remodel the Redox Homeostasis to Inhibit Ferroptosis in Intervertebral Disc Degeneration.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42621705PubMed
42,196,304The Mechanistic Review of the Molecular Interface of RNA-Loaded Extracellular Vesicles: Redefining Targeted Therapy for Autoimmune Disorders.Int J Mol Sci2026https://conductscience.org/library/papers/42196304PubMed
42,149,371Advances in Polydopamine-Based Nanoplatforms: Antioxidant Mechanisms and Applications in Oxidative Stress-Mediated Diseases.Nanomicro Lett2026https://conductscience.org/library/papers/42149371PubMed
41,994,115Design and Synthesis of Odorranalectin-Derived Peptides for RNA Binding.Res Sq2026https://conductscience.org/library/papers/41994115PubMed
41,750,365mRNA-Encoded Antibodies: An Emerging Paradigm in Antiviral Protection.Biomolecules2026https://conductscience.org/library/papers/41750365PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41535643

GET https://conductscience.org/api/papers/v1/41535643/references?page=2

API referenceFor AI assistants